Medical network on July 6 - li hua (a pseudonym) is 44 medicare varieties negotiation involves a business person, he said in the last week, he has little idea tube something else, bent on people club department website, from Monday to Wednesday can also have a little relaxed mood, half an hour to refresh people club department website at a time. By Thursday, the mood began to get tense, and from Thursday afternoon until Friday, the frequency of the refreshers' website had almost changed to two minutes.
But it wasn't until 6pm on June 30 that the results were expected...
On June 16, the 44 health insurance varieties negotiations finally entered the social work schedule. On June 24th, after 44 varieties of medicare drug price talks, people club department formally signed with negotiations enterprise, according to the participation of the enterprises, the site also held a small ceremony, perhaps is the meaning of start smoothly.
The price of some exclusive products and key products has fallen by more than 40 percent, the information said. There are 10 per cent varieties, which are agreed upon in price or not in the price line of the negotiating group. And some traditional Chinese medicine varieties have reduced prices less...
These are more nebulous before the final results are released. But it is certain that the ministry has made a plan for the use of the 1.26 trillion yuan insurance fund.
On June 29, li hua from people club department website refresh to the director-general of the department of the ministry of social health insurance Chen Jinfu online interview, Chen Jinfu said, will establish regional health care resources, total medical costs and the level of economic development, appropriate to the macroeconomic regulation and control mechanism of medical insurance fund supporting ability, effectively control cost excessively rapid growth of...
The relationship between capital and expenses
Li hua remembers that drug price negotiations began to circulate in the industry last year, when 45 varieties were introduced. This year on April 14, people club department issued "about 2017 national basic medical insurance, inductrial injury insurance and maternity insurance drug catalogue negotiations range of circular, include directory of drugs for 44.
The reason for the drug price negotiation is the relationship between health insurance funds and medical expenses. According to the audit office's 2017 release, the social department's health insurance fund for 2016 is 1.26 trillion yuan.
China's pharmaceutical market is expected to grow by more than 13 percent in 2016, according to people familiar with the medical association. The prescription drug market is over 800 billion.
In other words, the rapid growth of medical costs in the medicare payments for prescription drugs is putting pressure on the use of health care funds. Some provinces have come under intense pressure.
As a result, the patient just needed the class medicine, the price of high class drugs to enter the price reduction sequence.
It is understood that among the 44 negotiation varieties, 32 companies are involved, 19 are domestic varieties, 18 domestic enterprises are involved, and 25 imported drugs involve 14 foreign drug companies.
About the rules of the negotiations, according to the enterprise, the negotiating team have done a lot of research work before negotiations, price negotiation standards according to the experts for some drugs and after the research, the research content includes product innovation, the leading, alternative, and the current price. After the survey, the content formed a set of criteria.
It is understood that substitutable strong products, the price decline is very big. Some of the news showed that the talks were quiet and serious, cutting prices especially hard, beyond the expectations of companies. The average price cut for some, or exclusive, or weightier varieties is more than 40%. Some business people, full of sweat, holding the wall out...
According to live close to the negotiations of media information, through negotiations, 44 varieties, out of about 10%, with Merck snow pock cetuximab injection, love can tyrone wave raw temple, tasly injection gas after pulse (lyophilization) and yeung sum of injection with the British, xidan (limited crohn's disease).
Amount and price
In 44 varieties, sales to double digit of 5 varieties, namely green pharmaceutical injections of paclitaxel liposome, roche three double-digit sales of varieties, good form of injection, injection by bead but kang, beacizumab bead single injection, outside, red sun pharmaceutical blood will net injection.
Green leaf pharmaceutical injection with paclitaxel liposomes is the domestic exclusive dosage form, the absolute dominance of taxol market, the drug mainly treats ovarian cancer, non-small cell lung cancer, stomach cancer. In 2015, the sales volume of the single drug reached 21.77 billion yuan, 30 mg specifications, with a single cost of 1025 yuan. People in the industry said they had to cut prices because they were selling too much.
Among the 44 varieties of negotiations, roche accounted for 4 varieties, which were beneficial to the injection of tuximab. In 2015, China's sales volume was 2.051 billion yuan, and the single price was 3866.8 yuan. The name of the drug, mei luo hua, was listed in 2000 and used for lymphoma. In this catalogue, there are several imported tini and monoclonal antitumor drugs. For years, companies say, drug tenders have failed to reduce the price of such varieties, and can now be reduced only by price negotiation. Indications in addition, the varieties on the market for many years, with the market competition is becoming more and more fierce, the future may also face generic competition, domestic enterprises to participate in price negotiations now, into the insurance reimbursement, perhaps is the best choice.
Roche's other two drugs, one of which was used for metastatic breast cancer, was used for metastatic breast cancer, with a single price of $21809.6 for the $19.12 billion in 2015. Bevacizumab injection was used for metastatic colorectal cancer and bevacizumab combined with 5-fluorouracil for chemotherapy for metastatic colorectal cancer patients. And, with advanced, metastatic or recurrent non-small cell lung cancer, beacizumab bead sheet resistance plus carboplatin and paclitaxel for unresectable advanced, metastatic or recurrent squamous cell the first-line therapy for patients with non-small cell lung cancer. In 2015, the sales volume was 1.31.1 billion yuan, with a single price of 5210 yuan...
Roche's other drug, erlotinib hydrochloride tablets, had sales of 624 million yuan in 2015.
The cetuximab injection of Merck snow lenol was used for the treatment of metastatic rectal cancer with chemotherapy regimen. In 2015, China's sales volume was 619 million yuan, with a single price of 4,468 yuan.
Red sun pharmaceutical blood will net injection is tianjin red sun take charge of varieties, previously in multiple places into supplementary health insurance, used in warm diseases, disease see fever, shortness of breath, palpitation, irritability, etc stasis poison each knot; Applicable to systemic inflammatory response syndrome induced by infection; It can also be used to treat the function of organ dysfunction syndrome. In 2015, sales were 20.1 billion yuan, or 44.6 yuan.
Tianshili's injection of yiqi (freeze-dried), used for coronary heart disease, is one of the main products of the natural force, with sales of RMB 709 million in 2015, and a single price of 40.4 yuan...
According to the analysis of the pharmaceutical enterprises, most of the 44 negotiation varieties are essential medicines, and in the context of reducing the medical costs of patients, it is also a good choice for drug companies to reduce the price.
It is unclear how much of the sales of drug companies involved in the negotiating variety will be reduced through negotiations. One drug company official said that the ministry had been very careful in negotiating the price of the drug, and that it could be published after it had been submitted.
However, the local health care directory will be completed by July 31, 2017, according to the ministry of human resources. Perhaps the outcome of the negotiations will be announced soon.
|
